When: Mon., Jan. 23, 9 a.m.-6 p.m. and Tue., Jan. 24, 9 a.m.-6 p.m. 2017
Overview: Quality control and related contract laboratories are considered at high risk because after testing and approval, drug products and Active Pharmaceutical Ingredients (APIs) are released to the market without further check. That's the reason why the FDA and other agencies put highest emphasis on inspections of QC laboratories. Even though cGMP regulations have been in place since long time, the large number of QC related 483's and warning letters demonstrate that companies have problems with implementation.
Price: ₹ 14,000